TIANJIN, China, Feb. 26, 2025 /PRNewswire/ -- The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application. The major issue focuses on mesenchymal stem cells...
The debate on MSCs is over; it's time to promote MSC therapy in practice
Seeking Alpha / 3 hours ago 2 Views
Comments